Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
- PMID: 24255610
- PMCID: PMC3832307
- DOI: 10.5581/1516-8484.20130104
Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interest
Comment on
- Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation. :343–346.
Similar articles
-
Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation.Rev Bras Hematol Hemoter. 2013;35(5):343-6. doi: 10.5581/1516-8484.20130099. Rev Bras Hematol Hemoter. 2013. PMID: 24255618 Free PMC article.
-
Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.Bone Marrow Transplant. 2008 Jan;41(2):167-72. doi: 10.1038/sj.bmt.1705953. Epub 2008 Jan 7. Bone Marrow Transplant. 2008. PMID: 18176620 Review.
-
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.Pediatr Blood Cancer. 2014 Jan;61(1):95-101. doi: 10.1002/pbc.24648. Epub 2013 Aug 11. Pediatr Blood Cancer. 2014. PMID: 23934933 Clinical Trial.
-
Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission.Leukemia. 1997 Sep;11(9):1533-9. doi: 10.1038/sj.leu.2400753. Leukemia. 1997. PMID: 9305609 Clinical Trial.
-
Autologous hematopoietic stem cell transplantation for pediatric solid tumors.Expert Rev Anticancer Ther. 2005 Oct;5(5):835-46. doi: 10.1586/14737140.5.5.835. Expert Rev Anticancer Ther. 2005. PMID: 16221053 Review.
References
-
- Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Hass-Kogan D, et al. Long term results for children with high risk neuroblastoma treated won a randomized trial of myeloablative therapy followed by 13-cis retinoic acid: a children's oncology group study. J Clin Oncol. 2009;27(7):1007–1013. - PMC - PubMed
-
- Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, et al. Treatment of relapsed Wilms tumor with high dose therapy and autologous hematopoietic stem cell rescue, the experience at Children's Memorial Hospital. J Clin Oncol. 2004;22(14):2885–2890. - PubMed
-
- Agarwal R, Dvorak CC, Stockerl-Goldstein KE, Johnston L, Srinivas S. Highdose chemotherapy followed by stem cell rescue for highrisk germ cell tumors: the Stanford experience. Bone Marrow Transplant. 2009;43(7):547–552. - PubMed
-
- Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M. Tandem highdose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with highrisk Ewing family tumors. Pediatr Blood Cancer. 2007;49(2):196–198. Comment in: Pediatr Blood Cancer. 2007;49(2):115-6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources